Study | Design | Country | Setting | HIV care payer | Years | N | Pregnancy status | ART regimen |
Ciambrone32 | Interview | Puerto Rico | Antenatal clinic (general) | ART and other costs not reported | 2003 | 17 | 12 pregnant, five postpartum | Unspecified |
Ekama29 | Semistructured questionnaire | Nigeria | Antenatal clinic (HIV-specific) | Government-funded ART; other costs not reported | 2009 | 170 | Pregnant | Unspecified |
Ferguson37 | Semistructured interview | Kenya | Antenatal clinic (general) | Government-funded ART; cost to attend clinic | 2010 | 19 | Pregnant | AZT, co-trimoxazole |
Katiyari40 | Focus group discussions and in-depth interviews | Swaziland | Antenatal clinic (general) | Government-funded ART; transportation costs | 2011, 2012 | 83 | Postpartum | AZT (14 weeks until delivery); lamivudine, AZT (7 days postpartum) |
Katiyari7 | Focus group discussions and in-depth interviews | Swaziland | Antenatal clinic (general); both private and public | Government-funded ART; other fees not reported | 2013 | 132 | 38 pregnant, 94 postpartum | Tenofovir, lamivudine, and efavirenz |
Kim8 | Interview | Malawi | Antenatal clinic (general) | Government-funded ART; transportation costs | 2014 | 65 | Pregnant | Tenofovir, lamivudine, and efavirenz |
Kohler38 | Structured questionnaire | Kenya | Antenatal clinic (general) | ART and other costs not reported | 2011 | 213 | Postpartum | Unspecified |
Mawar30 | In-depth interview | India | Antenatal clinic (general) | ART costs covered through this study; other costs not reported | 2001 | 31 | 6 pregnant, 5 admitted for delivery, 20 postpartum | AZT |
McDonald34 | In-depth interview | Australia | Research setting (not clinic) | ART and other costs not reported | 2001 | 16 | Postpartum | Unspecified, but AZT mentioned in quotes |
Ndlovu31 | In-depth interview | Zimbabwe | Research setting (not clinic) | ART and other costs not reported | 2005 | 15 | Couples desiring and/or intending to have children | Unspecified |
Richter36 | Focus groups | USA | Research setting (not clinic) | ART and other costs not reported | Not reported | 33 | Women considering pregnancy | AZT |
Siegel39 | Focused interviews | USA | Research setting (not clinic) | ART and other costs not reported | 1996 to 1997 | 51 | 11 pregnant, 6 planning to become pregnant, 25 considering pregnancy, 9 postpartum | AZT |
Sowell35 | Semistructured questionnaire | USA | Research setting (not clinic) | ART and other costs not reported | 1998 to 1999 | 322 | 61 considering pregnancy, 261 postpartum | AZT |
Stinson33 | Interview | South Africa | Antenatal clinic (general) | Government funded ART; Transportation costs | 2007 to 2008 | 28 | 17 pregnant, 11 postpartum | Unspecified |
Zhou9 | Interview | Malawi | Antenatal clinics (general and HIV specific) | Government funded ART; Other fees not reported | 2014 | 65 | Pregnant | Tenofovir, lamivudine, and efavirenz |
ART, antiretroviral therapy; AZT, zidovudine; N, number of women participants.